In Figure 4A the corrected relative hazard against the percentage of Nectin 4 positive tumor cells is shown indicating a negative impact on OS in tumors with >50% and therefore this cutoff was used for outcome analyses. This evidence concerns the gene NECTIN4 and neoplasm.